Condition : Rheumatic Arthritis Interventions : Drug: Unani Therapy; Drug: Placebo Sponsors : Macmillan Research Group UK; Saibliss Healthcare Vision Completed - verified December 2013

Condition : Arthritis, Rheumatoid Interventions : Biological: adalimumab 40 mg; Biological: sirukumab 100 mg; Biological: sirukumab 50 mg; Drug: Placebo Sponsor : Janssen Research & Development, LLC N...

Condition : Rheumatoid Arthritis Intervention : Other: Nurse-led clinic Sponsors : Vastra Gotaland Region; Göteborg University Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Recruiting - verified February 2014

Condition : Spondylitis, Ankylosing Interventions : Drug: Secukinumab; Drug: Secukinumab; Drug: Placebo secukinumab Sponsors : Novartis; Novartis Pharmaceuticals Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: Clazakizumab; Drug: Placebo (Matching with Clazakizumab) Sponsor : Bristol-Myers Squibb Recruiting - verified February 2014

Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate; Drug: methylprednisolone Sponsor : Hoffmann-La Roche Completed - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Completed - verified February 2014

Condition : Rheumatoid Arthritis Intervention : Drug: tocilizumab [RoActemra/Actemra] Sponsor : Hoffmann-La Roche Not yet recruiting - verified February 2014

Conditions : Dry Eye Syndromes; Sjogren's Syndrome Intervention : Sponsor : University of Rochester Not yet recruiting - verified February 2014